Christopher Calio - Raytheon Technologies Chief Officer
| 0R2N Stock | 127.20 0.08 0.06% |
Executive
Christopher Calio is Chief Officer of Raytheon Technologies Corp
| Age | 50 |
| Address | 1000 Wilson Boulevard, Arlington, VA, United States, 22209 |
| Phone | 781 522 3000 |
| Web | https://www.rtx.com |
Raytheon Technologies Management Efficiency
The company has return on total asset (ROA) of 0.0326 % which means that it generated a profit of $0.0326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0813 %, meaning that it generated $0.0813 on every $100 dollars invested by stockholders. Raytheon Technologies' management efficiency ratios could be used to measure how well Raytheon Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Other Current Assets is likely to gain to about 7 B in 2025, whereas Total Assets are likely to drop slightly above 152.7 B in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Roger Farah | CVS Health Corp | 72 | |
| Larry McGrath | CVS Health Corp | N/A | |
| David CEBS | CVS Health Corp | 60 | |
| Laurence McGrath | CVS Health Corp | N/A | |
| Alan MD | CVS Health Corp | 62 | |
| Norman Greve | CVS Health Corp | N/A | |
| Victoria Hargreaves | Optima Health plc | N/A | |
| Lloyd Price | Induction Healthcare Group | N/A | |
| Sheryl Burke | CVS Health Corp | N/A | |
| Sreekanth MD | CVS Health Corp | 44 | |
| David Falkowski | CVS Health Corp | N/A | |
| Louise Torr | Induction Healthcare Group | N/A | |
| Martin Paxton | Optima Health plc | N/A | |
| Noel McElearney | Optima Health plc | N/A | |
| Guy Mitchell | Induction Healthcare Group | 50 | |
| Heidi Capozzi | CVS Health Corp | 55 | |
| Brenda Orelu | Optima Health plc | N/A | |
| Andrew Williams | Induction Healthcare Group | 65 | |
| Laurie Havanec | CVS Health Corp | 63 | |
| Laura Towse | Abingdon Health Plc | N/A | |
| Tilak Mandadi | CVS Health Corp | 60 | |
Management Performance
| Return On Equity | 0.0813 | ||||
| Return On Asset | 0.0326 |
Raytheon Technologies Leadership Team
Elected by the shareholders, the Raytheon Technologies' board of directors comprises two types of representatives: Raytheon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Raytheon. The board's role is to monitor Raytheon Technologies' management team and ensure that shareholders' interests are well served. Raytheon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Raytheon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Timm, President Systems | ||
| Christopher Calio, Chief Officer | ||
| Shane Eddy, President Whitney | ||
| Gregory Hayes, Executive Chairman | ||
| Neil Mitchill, Chief Officer | ||
| Robin Diamonte, Chief Investments | ||
| Amy Johnson, Corporate Controller | ||
| Dantaya Williams, Executive Officer | ||
| Pamela Erickson, Chief Officer | ||
| Gregory CPA, Executive Chairman | ||
| Mark Russell, VP Officer | ||
| Juan Bedout, Chief Officer | ||
| Jennifer Reed, Vice Relations | ||
| Ramsaran Maharajh, Executive Counsel | ||
| Christopher McDavid, Co Compliances | ||
| Wesley Kremer, Executive Officer | ||
| Michael Dumais, Strategic Advisor |
Raytheon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Raytheon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0813 | ||||
| Return On Asset | 0.0326 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 208.82 B | ||||
| Shares Outstanding | 791.3 M | ||||
| Shares Owned By Insiders | 0.39 % | ||||
| Shares Owned By Institutions | 81.79 % | ||||
| Price To Sales | 1.01 X | ||||
| Revenue | 80.74 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Raytheon Stock Analysis
When running Raytheon Technologies' price analysis, check to measure Raytheon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raytheon Technologies is operating at the current time. Most of Raytheon Technologies' value examination focuses on studying past and present price action to predict the probability of Raytheon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raytheon Technologies' price. Additionally, you may evaluate how the addition of Raytheon Technologies to your portfolios can decrease your overall portfolio volatility.